Elanco Animal Health
Open
$22.15
Prev. Close
$22.15
High
$22.15
Low
$22.15
Market Snapshot
$10.83B
-46.7
0.68
$4.44B
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Indianapolis, Indiana and currently employs 9,400 full-time employees. The company went IPO on 2018-09-20. The firm's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). The company has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The firm's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
emptyResult
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Indianapolis, Indiana and currently employs 9,400 full-time employees. The company went IPO on 2018-09-20. The firm's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). The company has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The firm's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Recently from Cashu
Elanco Animal Health Partners with Medgene for Avian Influenza Vaccine Development
Elanco Animal Health Partners with Medgene for Avian Influenza Vaccine Development Elanco Animal Health Incorporated announces a strategic partnership with Medgene, a South Dakota-based biotechnology…
Elanco Animal Health Engages Stakeholders at Key Investor Conferences
Elanco Animal Health Engages Stakeholders Through Investor Conferences Elanco Animal Health Incorporated demonstrates its proactive approach in stakeholder engagement by announcing participation in a…
Elanco Animal Health Strengthens Education Following FDA Warning on Zenrelia Promotion
Elanco Animal Health Enhances Educational Commitment Following FDA Warning Letter Elanco Animal Health Incorporated takes a significant step towards improving communication and education for veterinar…
Elanco Animal Health Strengthens Education Efforts After FDA Warning on Zenrelia Promotion
Elanco Animal Health Reinforces Commitment to Education Following FDA Warning Elanco Animal Health Incorporated is taking significant steps to enhance its educational outreach to veterinarians and pet…